A Multi-marker Integrative Analysis Reveals Benefits and Risks of Bariatric Surgery
Authors
Affiliations
Bariatric surgery (BS) is an effective intervention for severe obesity and associated comorbidities. Although several studies have addressed the clinical and metabolic effects of BS, an integrative analysis of the complex body response to surgery is still lacking. We conducted a longitudinal data study with 36 patients with severe obesity who were tested before, 6 and 12 months after restrictive BS for more than one hundred blood biomarkers, including clinical, oxidative stress and metabolic markers, peptide mediators and red blood cell membrane lipids. By using a synthetic data-driven modeling based on principal component and correlation analyses, we provided evidence that, besides the early, well-known glucose metabolism- and weight loss-associated beneficial effects of BS, a tardive, weight-independent increase of the hepatic cholesterol metabolism occurs that is associated with potentially detrimental inflammatory and metabolic effects. Canonical correlation analysis indicated that oxidative stress is the most predictive feature of the BS-induced changes of both glucose and lipids metabolism. Our results show the power of multi-level correlation analysis to uncover the network of biological pathways affected by BS. This approach highlighted potential health risks of restrictive BS that are disregarded with the current practice to use weight loss as surrogate of BS success.
Severa M, Ricci D, Etna M, Facchini M, Puzelli S, Fedele G Vaccines (Basel). 2024; 12(9).
PMID: 39340080 PMC: 11436141. DOI: 10.3390/vaccines12091050.
The dual nature of DNA damage response in obesity and bariatric surgery-induced weight loss.
Escobar Marcillo D, Guglielmi V, Privitera G, Signore M, Simonelli V, Manganello F Cell Death Dis. 2024; 15(9):664.
PMID: 39256343 PMC: 11387396. DOI: 10.1038/s41419-024-06922-0.
Female obesity: clinical and psychological assessment toward the best treatment.
Guglielmi V, Dalle Grave R, Leonetti F, Solini A Front Endocrinol (Lausanne). 2024; 15:1349794.
PMID: 38765954 PMC: 11099266. DOI: 10.3389/fendo.2024.1349794.
Pradel-Mora J, Marin G, Castillo-Rangel C, Hernandez-Contreras K, Vichi-Ramirez M, Zarate-Calderon C Plast Reconstr Surg Glob Open. 2024; 12(3):e5646.
PMID: 38515558 PMC: 10956951. DOI: 10.1097/GOX.0000000000005646.
The Crosstalk between Gut Microbiota and White Adipose Tissue Mitochondria in Obesity.
Colangeli L, Escobar Marcillo D, Simonelli V, Iorio E, Rinaldi T, Sbraccia P Nutrients. 2023; 15(7).
PMID: 37049562 PMC: 10097238. DOI: 10.3390/nu15071723.